First Time Loading...
N

Nichi-Iko Pharmaceutical Co Ltd
TSE:4541

Watchlist Manager
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Watchlist
Price: 0.0001 JPY Market Closed
Updated: Apr 29, 2024

Nichi-Iko Pharmaceutical Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nichi-Iko Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Net Income (Common)
-¥105B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Income (Common)
¥178.2B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
2%
Daiichi Sankyo Co Ltd
TSE:4568
Net Income (Common)
¥186.1B
CAGR 3-Years
38%
CAGR 5-Years
23%
CAGR 10-Years
5%
Otsuka Holdings Co Ltd
TSE:4578
Net Income (Common)
¥121.6B
CAGR 3-Years
-6%
CAGR 5-Years
8%
CAGR 10-Years
-4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Income (Common)
¥325.5B
CAGR 3-Years
15%
CAGR 5-Years
29%
CAGR 10-Years
20%
Astellas Pharma Inc
TSE:4503
Net Income (Common)
¥37.3B
CAGR 3-Years
-35%
CAGR 5-Years
-29%
CAGR 10-Years
-9%

See Also

What is Nichi-Iko Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
-105B JPY

Based on the financial report for Mar 31, 2022, Nichi-Iko Pharmaceutical Co Ltd's Net Income (Common) amounts to -105B JPY.

What is Nichi-Iko Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-2 412%

Over the last year, the Net Income (Common) growth was -2 412%.